[1] Carvalho S, Schmitt F.Potential role of PI3K inhibitors in the treatment of breast cancer[J].Future Oncol, 2010, 6(8):1251-1263. [2] Sheppard K, Kinross KM, Solomon B, et al.Targeting PI3kinase/AKT/mTOR signaling in cancer[J].Crit Rev Oncog, 2012, 17(1):69-95. [3] Zheng W, Wang H, Zeng Z, et al.The possible role of the Akt signaling pathway in schizophrenia[J].Brain Res, 2012, 1470:145-158. [4] Okumura N, Yoshida H, Kitagishi Y, et al.PI3K/AKT/PTEN signaling as a molecular target in leukemia angiogenesis[J].Adv Hematol, 2012, 2012:843085. [5] Jo J, Whitcomb DJ, Olsen KM, et al.Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β[J].Nat Neurosci, 2011, 14(5):545-547. [6] Gao C, Holscher C, Liu Y, et al.GSK3:a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease[J].Rev Neurosci, 2011, 23(1):1-11. [7] Malik M, Tauqeer Z, Sheikh AM, et al.NF-κB signaling in the brain of autistic subjects[J].Mediators Inflamm, 2011, 2011:785265. [8] Huttemann M, Helling S, Sanderson TH, et al.Regulation of mitochondrial respiration and apoptosis through cell signaling:cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation[J].Biochim Biophys Acta, 2012, 1817(4):598-609. [9] Angelidou A, Asadi S, Alysandratos KD, et al.Perinatal stress, brain inflammation and risk of autism-review and proposal[J].BMC Pediatr, 2012, 12(89):1471-2431. [10] Malik M, Sheikh AM, Wen G, et al.Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects[J].Immunobiology, 2011, 216(1-2):80-85. [11] Scattoni ML, Martire A, Cartocci G, et al.Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+tf/J strain, a mouse model of autism[J].Behav Brain Res, 2013, 251:35-40. [12] Correia CT, Coutinho AM, Sequeira AF, et al.Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism[J].Genes Brain Behav, 2010, 9(7):841-848. [13] Sheikh AM, Malik M, Wen G, et al.BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects[J].J Neurosci Res, 2010, 88(12):2641-2647. [14] Zhou J, Parada LF.PTEN signaling in autism spectrum disorders[J].Curr Opin Neurobiol, 2012, 22(5):873-879. [15] Sperow M, Berry RB, Bayazitov IT, et al.Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration[J].J Physiol, 2012, 590(Pt4):777-792. [16] Go HS, Kim KC, Choi CS, et al.Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway[J].Neuropharmacology, 2012, 63(6):1028-1041. [17] Garcia-Penas JJ, Carreras-Saaez I.Autism, epilepsy and tuberous sclerosis complex:a functional model linked to mTOR pathway[J].Rev Neurol, 2013, 22(56S):153-161. [18] Ehninger D, Silva AJ.Rapamycin for treating Tuberous sclerosis and autism spectrum disorders[J].Trends Mol Med, 2011, 17(2):78-87. [19] Sheikh AM, Li X, Wen G, et al.Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects[J].Neuroscience, 2010, 165(2):363-370. [20] Malik M, Sheikh AM, Wen G, et al.Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects[J].Immunobiology, 2011, 216(1-2):80-85. [21] Wei H, Malik M, Sheikh AM, et al.Abnormal cell properties and down-regulated FAK-Src complex signaling in B lymphoblasts of autistic subjects[J].Am J Pathol, 2011, 179(1):66-74. [22] Go HS, Seo JE, Kim KC, et al.Valproic acid inhibits neural progenitor cell death by activation of NF-κB signaling pathway and up-regulation of Bcl-XL[J].J Biomed Sci, 2011, 18(1):48. [23] Napoli E, Ross-Inta C, Wong S, et al.Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior:interplay between Pten and p53[J].PLoS One, 2012, 7(8):e42504. [24] Bartzokis G.Neuroglialpharmacology:myelination as a shared mechanism of action of psychotropic treatments[J].Neuropharmacology, 2012, 62(7):2137-2153. [25] Mines MA, Yuskaitis CJ, King MK, et al.GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism[J].PLoS One, 2010, 5(3):e9706. [26] Tsai PT, Hull C, Chu Y, et al.Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice[J].Nature, 2012, 488(7413):647-651.
PDF(581 KB)
